Scientific research and breakthroughs that double cancer survival and tackle over 200 types of cancer.
Cancer Research UK: Scientific research and breakthroughs that double cancer survival… · Jul 15–Aug 17, 2026
RenewingThe campaign explains how DNA copying errors can lead to cancer and presents Cancer Research UK's scientists as the solution, having doubled UK cancer survival and driving discoveries for over 200 types of cancer.
13-week activity
Public campaign reads by observed week
Renewal signals
No recurring promo code was observed.
Problem-solution framing, detailing how DNA errors lead to cancer and how scientific research provides solutions.
Shows
Where the campaign appearedPlacements
Categories
Representative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
This episode is brought to you by Cancer Research UK. Our bodies are incredible machines, whirring away, making more and more DNA to build the proteins that keep us alive. In fact, in the last minute, your body has made over 200 million new cells and enough DNA to stretch to the moon and back. To the moon and back. That's so much DNA that if you compared it to the size of the cell it fits into, that would be like squeezing the London Underground into a suitcase. By the age of 50, you have copied almost 6 trillion miles of DNA. But every time that your body copies DNA, it risks making mistakes. And over time, those mistakes can accumulate and that collection of errors can lead to cancer. But incredibly, Cancer Research UK scientists can spot these errors. And by finding them, they've helped double UK cancer survival over the last 50 years and are driving even more discoveries that could tackle over 200 types of cancer. For more information about Cancer Research UK, their research and breakthroughs and how you can support them, visit cancerresearchuk.org slash rest is science.
More campaigns from Cancer Research UK
Other published campaigns from this sponsor
Cancer Research UK's campaign focuses on their research to mitigate the lifelong side effects of cancer treatments in children and young people, citing a clinical trial that nearly halved hearing loss.
The campaign highlights Cancer Research UK's scientific research and breakthroughs in tackling over 200 types of cancer, emphasizing their historical impact on UK cancer survival and inviting support for their ongoing work.
The campaign highlights Cancer Research UK's pioneering work in immunotherapy, specifically CAR T-cell therapy for blood cancers and solid tumors, and its historical contribution to doubling cancer survival in the UK.
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.